CA2082427C - Prosthetic intervertebral disc - Google Patents

Prosthetic intervertebral disc

Info

Publication number
CA2082427C
CA2082427C CA 2082427 CA2082427A CA2082427C CA 2082427 C CA2082427 C CA 2082427C CA 2082427 CA2082427 CA 2082427 CA 2082427 A CA2082427 A CA 2082427A CA 2082427 C CA2082427 C CA 2082427C
Authority
CA
Grant status
Grant
Patent type
Prior art keywords
disc
fibers
intervertebral
prosthetic
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 2082427
Other languages
French (fr)
Other versions
CA2082427A1 (en )
Inventor
Kevin R. Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ReGen Biologics Inc
Original Assignee
ReGen Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/3872Meniscus for implantation between the natural bone surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30756Cartilage endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth
    • A61F2/30907Nets or sleeves applied to surface of prostheses or in cement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30965Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30112Rounded shapes, e.g. with rounded corners
    • A61F2002/30131Rounded shapes, e.g. with rounded corners horseshoe- or crescent- or C-shaped or U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30205Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • A61F2002/3023Three-dimensional shapes cylindrical wedge-shaped cylinders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30721Accessories
    • A61F2/30734Modular inserts, sleeves or augments, e.g. placed on proximal part of stem for fixation purposes or wedges for bridging a bone defect
    • A61F2002/30736Augments or augmentation pieces, e.g. wedges or blocks for bridging a bone defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30756Cartilage endoprostheses
    • A61F2002/30766Scaffolds for cartilage ingrowth and regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes, grooves
    • A61F2002/3082Grooves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes, grooves
    • A61F2002/30878Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes, grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • A61F2002/30879Ribs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes, grooves
    • A61F2002/30904Special external and/or bone-contacting surfaces, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes, grooves serrated profile, i.e. saw-toothed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/30957Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using a positive or a negative model, e.g. moulds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4274Distal carpal row, i.e. bones adjacent the metacarpal bones
    • A61F2002/4276Trapezium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4274Distal carpal row, i.e. bones adjacent the metacarpal bones
    • A61F2002/4279Trapezoid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4274Distal carpal row, i.e. bones adjacent the metacarpal bones
    • A61F2002/4282Capitate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4274Distal carpal row, i.e. bones adjacent the metacarpal bones
    • A61F2002/4284Hamate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4287Proximal carpal row, i.e. bones adjacent the radius and the ulna
    • A61F2002/4289Scaphoid or navicular bone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4287Proximal carpal row, i.e. bones adjacent the radius and the ulna
    • A61F2002/4292Lunate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4287Proximal carpal row, i.e. bones adjacent the radius and the ulna
    • A61F2002/4294Triquetrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4261Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for wrists
    • A61F2002/4271Carpal bones
    • A61F2002/4287Proximal carpal row, i.e. bones adjacent the radius and the ulna
    • A61F2002/4297Pisiform bone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00365Proteins; Polypeptides; Degradation products thereof

Abstract

A prosthetic intervertebral disc (200) is disclosed which can be implanted in the human skeleton, and which can at as a scaffold for regrowth of intervertebral disc material. The disc (200), includes a dry, porous, volume matrix of biocompatible and bioresorbable fibers which may be interspersed with glycosaminoglycan molecules.
The matrix is adapted to have in vivo an outer surface contour substantially the same as that of a natural intervertebral disc, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of intervertebral fibrochondrocytes.
Cross-links may be provided by a portion of the GAG molecules.

Description

. M.-.

2 0 8 2 4 2 l PCT/US91/03106 PROSTHETIC INTERVERTEBRAL DISC
BACKGROUND OF THE DISCLOSURE
The present invention is in the field of implantable medical devices, and more particularly,.
is directed to devices useful as a prosthetic intervertebral disc.
The intervertebral disc acts in the spine as a crucial stabilizer, and as a mechanism for force distribution between the vertebral bodies. Without the disc, collapse of the intervertebral space occurs in conjunction with abnormal joint mechanics and premature development of arthritic changes.
Prior art methods of treating injured or diseased discs have included chemical disintegration procedures and surgical ezcision, often followed by bony fusion to prevent spinal collapse or instability. With ezcision, no significant ,._ W~~1/16867 ~ ~ ~ ~ ~ ~ 7 PCT/US91/03106 ,.
regeneration of vertebral tissue occurs. Replacement of an injured disc in an otherwise healthy spine may prevent arthritic changes and may stabilize the spinal segments. In disease8 spines replacement of the disc may reduce the progression of the disease process, and may provide pain relief.
In alternative prior art replacement approaches, discs have been replaced with prostheses compose3 of a: tificial ~:ater VaIJ. :'::c uss of gurelr artificial materials in the spine minimizes the possibility of an immunological response. In addition, such materials permit construction of a structure which can withstand the high and repeated loads seen by the spinal vertebral joints. and can alter the joint mechanics in beneficial ways that biological materials would not tolerate. For ezample. titanium, (Albrektsson et al. (1981) Acta Ortop. Scan. x:155-170), acrylic (Cleveland (1955) Marquette Med. Rev. ~"Q:62: Hamby et al.(1959) J.
Neurosurg. x,ø:311). polytetrafluorothylene-carbon fiber (Alitalo (1979) Acta Veterinaria Scandinavica Suppl. ~:1-58), and steel discs (Fenstrom (1973) Acta Chir. Stand. 4:165-186: French Patent No.
4,349.921) have been used to replace the resected disc. Each of these efforts have met with failure due to continued collapse of the disc space or erosion of the metal prosthesis into the surrounding bone.
A prosthetic intervertebral disc has also been constructed from resilient materials such as silicone rubber (e. g., Edeland (1985) J. Hiomed Eng.
7:57-62; Schneider et al. (1974) 2. Orthop.

WO 91/16867 2 o a 2 4 ~ 7 P~/US91/03106 x:1078-1086; Urbaniak et al. (1973) J. Hiomed.
Mater. Res. Symposium q:165-186). A disc has also '. been made from resilient plastic materials to form a bladder as disclosed in U.S. Patent Nos. 3.875.595 and 4,772,287; however, failure to restore full stability and normal joint biomechanics has prevented success. Porous elastomeric materials as described in U.S. Patent No. 4,349.921 have failure to recapitulate the normal vertebral body mechanics.
Generally, the replacement of intervertebral tissue With structures consisting of artificial materials has been unsuccessful principally because the opposing vertebral end plates of human and animal joints are fragile. The end plates in the spine will not withstand abrasive interfaces nor variances from normal compliance. which evidently result from the implantation of prior art artificial discs.
Additionally, joint forces are multiples of body weight which, in the case of the spine, are typically over a million cycles per year. Thus far, prior art artificial discs have not been soft or durable enough, nor have they been able to be positioned securely enough to withstand such routine forces.
Prostheses, in general, have been devised out of at least some of the constituents of the structures which they are replacing, or out of materials not considered to be immunogenic to the body. For ezample, Yannas et al. fashioned blood vessel grafts (U. S. Patent No. 4,350.629), synthetic epidermis (U. S. Patent No. 4,448,718), and sciatic nerve guides (WO 89/10728; Yannas (1979) Am. Chem.
Soc. x:209) out of collagen and glycosaminoglycans, wQ 91 ~' ~' 2 0 8 2 4 2 l P~~US91 /03106 biochemical components of many body organs. Hy adjusting the pore size and azes of the pores and fibers comprising these structures, regrowth of natural tissue could be stimulated. Further regrowth has been advanced by seeding of the nerve guide with Schwann cells prior to implantation (see U.S. Fatent No. 4,458,678). However, even with the foregoing technologies which have been applied to the reconstruction of anatomical structures other than intervertebral discs, a structure suitable as a prosthetic disc and constructed from natural materials has not yet been successfully developed.
Accordingly, it is an object of this invention to provide an intervertebral disc replacement or prosthesis.
Another object is to provide an improved disc replacement or prosthesis that does not interfere With normal vertebral segment motion as such interference could lead to a reduced range of motion or to focal concentration of force at other sites within the spinal column or instability of the opposing vertebral bodies, therefore enhancing the chances of progressive arthritic destruction.
Yet another object is to pzovide an improved disc replacement or prosthesis that is biomechanically able to withstand normal spinal column forces and is able to function at those loads to protect the opposing end plates and stabilize the joints.

W O 91/16867 2 p 8 2 4 2 7 P~/US91/03106 --Still another object is to provide an improved disc replacement or prosthesis Which promotes regrowth of intervertebral disc material and Which acts as a scaffold for fibrocartilage infiltration.
A further object is to provide an improved disc replacement or prosthesis does not evoke an immunologic reaction or aggrevate other joint structures.
Still a further object is to provide an improved meniscal replacement or prosthesis which can be easily implanted by standard operative techniques.

SL~~Rv OF THE INVENTION
The present invention provides a biocompatable and bioresorbable structure for implantation into the spine which assumes the form and role of an intervertebral disc. This matrix may promote regrowth of intervertebral fibrochondrocytes and provides a scaffold for the regenerating intervertebral disc tissue.
Tne prosthetic disc is composed of a dry, porous. volume matrix of biocompatable and bioresorbable fibers. The matrix is adapted to have ~ v'v an outer surface contour substantially the same as that of a natural intervertebral disc. A
portion of the fibers may be cross-linked.
The fibers include a natural fiber or an analog of a natural fiber such as a biosynthetic analog, or a synthetic fiber. or mixtures thereof. A
biosynthetic fiber is one which may be produced by recombinant DNA technology including the transfection of an appropriate host cell capable of protein expression with a gene encoding, for example, a recombinant protein such as collagen. A synthetic fiber is one which may be produced by chemical methods such as. automated peptide synthesis. In one preferred embodiment of the invention, the fibers of the matrix are polymers of, for example, natural molecules such as those obtained from animal or human tissue. Natural fibers useful for the same purpose preferably include collagen, elastin, reticulin, cellulose, analogs thereof, and mixtures thereof.
A

7 2 0 8 2 4 2 7 p~/US91/03106 _7-In some forms of the invention, the fibers may be randomly orientated throughout the matrix, or '. may be ordered at specified regions. Alternatively, the fibers may assume substantially circumferentially extending or substantially radially extending orientations throughout the prosthetic disc.
The matrix may also include glycosaminoglycan molecules (GAGS) interspersed with the fibers. GAGs are mucopolysaccharide molecules Which provide lubrication and may be included in cross-links for the prosthetic disc. In one preferred aspect of the invention, GAGS such as chondroitin 4-sulfate, chondroitin 6-sulfate, keratin sulfate. dermatan sulfate, heparan-sulfate, heparin, hyaluronic acid, and mixtures thereof form a component of the disc. The GAGS may be uniformly dispersed throughout the prosthetic disc as individual molecules, or may be present in varying amounts in different regions of the structure.
In various forms of the invention, GAGS may directly participate in covalent cross-linking with the fibers, or may interact with the fibers mechanically in the form of entanglement or through interlocking mechanisms, thereby forming various stable fiber-GAG complexes.
The matrix may include about 75-100% natural ' 30 and/or synthetic fibers and about 0-25% GAGS by dry weight, the proportions of which may be constant ' throughout the structure or may be variable.

WO 91/16867 . 2 0 8 2 4 2 l P~/US91/03106 _g_ In a preferred embodiment of the invention, the matriz has a density of about 0.07 to 0.50 g matriz/cm3, Where "g matriz/cm3" is a unit connoting .' the number of grams in a cubic centimeter of the matriz. In addition, the matriz may have an interfibrillary and intrafibrillary space of about 2 to 25 cm3/g matriz.
In another form of the invention, the prosthetic disc may further include a mesh composed of a bioresorbable. biocompatible material which is attached to lateral portions of the outer surface of the matriz. The mesh aids in the successful implantation of the prosthetic intervertebral disc into the intervertebral spaces by providing a temporary anchoring mechanism.
The present invention also includes a method of regenerating intervertebral disc tissue ~p vivo.
This method includes fabricating a prosthetic intervertebral disc of the type described above, and implanting it into the spine by surgical procedures.
The presence of the prosthetic disc stimulates disc tissue growth.
Further, the invention includes a method for fabricating a prosthetic intervertebral disc of the type described above. Generally, the method includes placing a plurality of fibers or fibers and GAGS into a mold having a shape useful for spine function, subjecting the fibers (and GAGs) in the mold to two cycles of freezing and thawing, contacting the fibers ' or the fibers and GAGs with a chemical cross-linking reagent such that the fibers then assume the shape of -~w 2082421 the mold, and lyophilizing the resulting structure to obtain a dry, porous. volume matriz.
The fibers may be laid down in a circumferential orientation by rotating the mold as they are placed therein. Alternatively, the fibers in the mold may be compressed with a rotating piston. Radial orientation of the fibers is produced by manually painting t3~e fibers in a linear, radially 1_f~ di rLsrtori f g=~li~.~..
Specific densities and pore sizes may be obtained in various regions of the matriz by compressing the fibers or fibers and GAGS in the mold prior to the second freeze-thaw cycle. and subsequent to the chemical cross-linking step. This may be accomplished by applying pressure to a specific region of the matriz with a piston of a predetermined shape.
In a preferred aspect of the invention, the cross-linking step is performed using chemical agents which form intramolecular and intermolecular cross-links. Useful chemical agents include, for ezample, glutaraldehyde, formaldehyde, biocompatible bifunctional aldehydea, carbodiimides, hezamethylene diisocyanate, bis-imidates, glyozal, polyglycerol polyglycidyl ether, glyozal, and miztures thereof.
Particularly useful cross-linking agents are 1-ethyl, 3-(3-dimethylami,nopropyl) carbodiimide, polyglycerol polyglycidyl ether, acyl azide, and glutaraldehyde.
In other aspects of the invention, an additional cross-linking step is performed by A

lyophilizing the chemically cross-linked disc and then subjecting it to dehydrothermal cross-linking procedures.
In yet another aspect, the present invention provides the use of a prosthetic intervertebral disc for regeneration of intervertebral tissue in vivo by surgical implantation of said disc into a spine, wherein said disc comprises a dry porous volume matrix of biocompatible and bioresorbable fibers, said matrix being adapted to have in vivo an outer surface contour substantially the same as that of a natural intervertebral disc, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of vertebral fibrochondrocytes, and wherein said scaffold and said ingrown fibrochondrocytes support natural intervertebral disc load forces.
The invention will next be described in connection with certain illustrated embodiments.
However, it should be clear that various modifications, additions, and deletions can be made without departing from the spirit or scope of the invention.
A

VfO 91/16867 2 p 8 2 4 2 7 P~/US91/0310G

BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing and other objects of this invention, the various features thereof, as well as the invention. itself, may be more fully understood from the following description, When read together with the accompanying drawings in which:
FIG. 1 is a simplified diagrammatic representation of the normal positioning of an intervertebral disc in native position in the human spine:
FIG. 2 shows a perspective view of an exemplary prosthetic intervertebral disc in accordance with the present invention;
FIG. 3 shows a sectional view along line 3-3 of the prosthetic intervertebral disc of FIG. 2;
FIG. 4 shows a perspective view of another exemplary prosthetic intervertebral disc;
FIG. 5A shows a perspective view of another exemplary prosthetic intervertebral disc including a mesh member; and FIG. 5B shows a sectional view along line 5B-5B of the prosthetic disc of FIG 5A;
FIG. 6 shows in section an exemplary mold for constructing a prosthetic intervertebral disc; and FIG. 7 shows in section an alternative mold for constructing a prosthetic intervertebral disc.

WO 91/16867 PC?/US91/03106 20824?7 p~SCRIPTION OF TH~ INVENTION
It has been discovered that a prosthetic intervertebral disc fabricated from biocompatible and bioresorbable fibers can be surgically implanted into the intervertebral space so as to provide normal joint motion and strength. This prosthetic intervertebral disc also acts as a scaffold for regenerating disc tissue whose ingrowth is encouraged by the physical C!:aractezistics of tre implanted device. Following implantation, tissue ingrowth, regeneration, and finally resorption of the scaffold.
natural intervertebratal tissue remains.
FIG. 1 shows the normal positioning of an intervertebral disc 100 in the human intervertebral space 110 between the vertebral bodies 120 and 130.
An exemplary prosthetic intervertebral disc 200 is shown in FIG. 2. The disc 200 is a generally porous, dry volume matriz which eztends circumferentially in about a central azis 10. As used herein, the term "volume matriz" refers to a porous array characterized by relatively comparable (but not necessarily equal) outer dimensions in three orthogonal directions (as contrasted with a sheet matriz which would have relatively comparable dimensions in two orthogonal directions but relatively small dimensions in a third orthogonal direction).
In the preferred form, prior to implantation, the prosthetic intervertebral disc 200 has the shape of a cylindrical pad, eztending circumferentially about the azis 10, and comprising a relatively high compliance central region 12 disposed about a relatively low compliance peripheral region 14. In FIG. 2, the separation of regions 14 and 12 is indicated generally by broken line 17, although the transition is normally gradual. In the preferred form, the top and bottom (as shown) surfaces of disc 200 are concave so that disc 200 has maximum height A
at its peripheral edge,of approximately 8 mm and a maximum radial dimension C of approximately 35 mm.
iu FIG. 3 shows a sectional view along line 3-3 of the prosthetic disc 200 shown in FIG. 2.
FIG. 4 shows an additional embodiment 220 of the present invention which is similar in composition to the prosthetic disc 200 depicted in FIG. 2. The prosthetic intervertebral disc 220 is similar to disc 200, but includes convex top and bottom surfaces and further includes a mesh member ZO extending from its lateral surface. The mesh member 20 is composed of a biocompatible, bioresorbable material. Following implantation, the mesh member 20 may be sutured to adjacent tissue to anchor the disc 220 in place. The mesh member 20 may function in this capacity until sufficient tissue ingrowth occurs to provide that function. Since the anchor function of mesh member 20 is only temporary, the mesh member 20 may be a ~1 mesh screen composed of absorbable suture materials such as polyglyconate, Dezon; or polydiozane (PDS) woven into a mesh. Alternatively, nonabsorbable suture materials such as expanded polytetrafluoroethylene (PTF'E) may be used.
FIGS. 5A and 5B show yet another embodiment 230 Which is similar to that of FIG. I but having * Trade mark Wp 91/1686? 2 0 ~ 2 4 2 l P~/US91/0310G

concave top and flat bottom surfaces. Other combinations might also be used.
In alternative forms of the invention, still other shapes than full cylinders may be used. For eaample, it is not required that the full 360° (about azis 10) pad be used if partial disc replacement is undertaken. For angular segment type discs, the cylindrical form may subtend any angle between zero ?0 a~d 360 degrees abaut axis 10. It is however important that the matriz have characteristics so that when implanted, at least the top and bottom surfaces substantially assume the shape or contour of a natural intervertebral disc.
The various embodiments of the invention may have certain densities of collagen fibers and dispersions of GAG molecules and cross-links that permit accommodation of differing stress levels, rates of ingrowth, and resiliency. Differing densities may be obtained ~ vivo where a device having uniform density is implanted, and body loading causes non-uniform compression of the device.
Alternatively, the prosthetic disc may be initially configured with non-uniform construction of a type so that the i,n vivo configuration provides the desired spatial densities and dispersions necessary for the desired function.
The prosthetic intervertebral disc may be fabricated of any biocompatible, bioresorbable fibers such as a natural material, an analog thereof or a synthetic material. The fibers are preferably polymeric in structure so that they can provide H'O 91/16867 2 0 8 2 4 2 7 P~/US91/03106 mechanical strength, protection, and lubrication while encouraging tissue ingrowth. Such polymeric fibers include. for ezample, collagen, reticulin, elastin, cellulose, and biosynthetic analogs thereof. These fibers may be ordered in substantially circumferentially-eztending oz substantially radially-eztending orientations, with the density of fibers being substantially uniform throughout the matriz. Alternatively, the matriz fibers may be unordered. In either the ordered or unordered configuration, the density of the fibers may be non-uniform. In the non-uniform configuration. relatively high densities of fibers may be established at anticipated points of high stress.
In an alternative aspect of the invention, the intrafibrillary (i.e., the space within the fiber) and interfibrillary (the space between the fibers) space is relatively high, a condition which promotes ingrowth of regenerated disc tissue. For ezample, the density of the intervertebral disc may be in the range of about 10-25 g matriz/cm3.
Alternatively, the intrafibrillary and interfibrillary space may be relatively low, a condition which provides superior cushioning, lubrication, and mechanical support for the intervertebral space, and which retards tissue and cell ingrowth, thereby diminishing the rate of scaffold resorption (e.g., density is in the range of about 2-10 g matria/cm3).
The temporary stability of the shape of the structure when ~ yivo, and the rate of disc ~.. J 91/16867 PC?/US91/03106 resorption, are both attributed to the effective cross-link formation between at least one portion of the fibers. The cross-linking reagents used with the above-noted fiber materials may be any biocompatible, bifunctional reagents which interacts with amino, carbonyl, or hydrozyl groups on a single fiber forming intramolecular cross-links, or on multiple fibers or on the fibers and the GAGs, resulting in covalent bond formation between adjacent molecules (intermolecular cross-links). Useful cross-linking reagents include aldehydes, hezamethylene diisocyanate, bisimidates. polyglycerol polyglycidyl ether, acyl azide, and carbodiimides.
The cross-linked device maintains a sufficient degree of hydrophilicity and elasticity which simulates the properties of the natural intervertebral disc, i.e., ability to sustain mechanical stress and to protect and lubricate articular surfaces. In addition, the structure provides an ideal environment for cell infiltration and eztracellular matriz synthesis and deposition, resulting in regeneration of natural disc tissue.
GAGS may be dispersed throughout the fibers. Alternatively, they may act as intermolecular cross-links between fibers. These GAGS typically include at least one of the group of molecules consisting of chondroitin 4-sulfate, chondroitin 6-sulfate, keratin sulfate, dermatan sulfate. heparan sulfate, heparin. and hyaluronic acid. The dispersion of GAG cross-links is preferably uniform, but may be more concentrated at anticipated points of high stress, typically at the - '~ 2082427 peripheral region 14, and less concentrated in the central region 12 (FIG. 2). In such configurations, the GAG concentration may be in the range of about 0-25~ in the distal region 14, and in the range of about 0-10~C in the central region 12. However, When uniform, the dispersion of GAGS throughout the prosthetic intervertebral disc may be, for ezample, in the range of about 1-15~C.
Intermolecular cross-links can also be established through a dehydrothermal process (heat and vacuum) which results in peptide bond formation between an epsilon amino group of lysine or hydrozylysine and a carbozyl group of aspartic or glutamic acid.
The cross-linked disc has a relatively high thermal stability at between about 55-85°C, and preferably at between about 65-75°C foz sufficient ~
v'v stability. This may be achieved through manipulation of the cross-linking conditions, including zeagent concentration, temperature, pH, and t ime ( see 1=XAMPLir 1 ) .
In a one embodiment the prosthetic intervertebral disc is constructed mainly of Type I
collagen fibers without GAG cross-links. Type I
collagen fibers may be obtained from the Achilles tendons of animals. However, the fibers may also be obtained from animal skin or from the skin or tendon of humans. The tissues are treated with a series of mechanical and chemical means to either totally remove the non-collagenous materials or reduce them to a minimal level. In the preferred processing steps, the tendon or skin is mechanically disintegrated into fine pieces useful for further processing. The disintegration may be achieved by grinding the tissue at liquid nitrogen temperature, or by cutting the tissue into small pieces with a sharp knife. In certain applications, the tendons are mechanically disintegrated along the fiber direction in order to maintain the length of the fibers for mechanical strength.
Salt eztraction of tendon at neutral pH
removes a small portion of the collagen molecules that are newly synthesized and have not yet been incorporated into the stable fibrils. Salt also removes some glycoproteins and proteoglycans that are associated with collagen through electrostatic interactions. Other salts such as KCl can be used as a substitute for NaCl.
Lipids that are associated with the cell membranes or collagenous matrices may be removed by first eztracting with detergents such as Triton X-100 (Sigma Chemical Co., St. Louis, Missouri), followed by eztracting with ether-ethanol miztures. The concentration of Triton X-100*is usually about 2-4~, but is preferably about 3~. The preferred mizture of ether-ethanol is usually at about a l:l ratio (v/v).
The period of eztraction is usually from B hours to 96 hours. and is preferably from about 24 to 48 hours.
Further eztraction may be accomplished by matriz swelling conducted at two eztreme pHs. Both acidic and basic swelling weakens the non-covalent intermolecular interactions, thus facilitating the * Trade mark A

~..~ 91/16867 PCT/US91/03106 . 2082427 release of non-covalently attached glycoproteins, GAGS, and other non-collagenous molecules through the open pores of the collagenous matrices.
The swelling of the collagenous matriz at alkaline pH is performed by treating the collagen at high pH with Ca(OH)2, NaOH, or the like, for a period of about 8-96 hours. Alkali eztraction in the presence of triple-helical stabilizing salts such as (CH3)NC1 or NH3SOa_ reduces the potential risk of denaturation of the collagen. Alkali treatment dissociates the non-cross-linked glycoproteins and GAGs from the collagen matrices. The alkali also removes the residual lipids through saponification.
Acid swelling may be conducted at a low pH
in the presence of acetic acid, HC1. or similar acids. Like the alkali treatment, the swelling removes non-cross-linked glycoproteins and GAGS.
The non-triple helical portions of the molecule (telopeptides) are involved in intermolecular cross-linking formation. They are weak antigens and are susceptible to attack by proteases such as pepsin and trypsin. Prolonged digestion with such proteases dissociates the fibrils (fibers) into individual molecules. However, if the digestion process is properly controlled such that mazimal telopeptides are removed without complete dissociation, the immunogenic properties of the fibrils can be reduced to a minimal level without compromising the mechanical strength. For ezample, to isolate molecular collagen, the digestion of skin or tendon with pepsin is usually conducted at an ..O 91/16867 PCTlLS91/03106 enzyme:collagen ratio of about 1:10 for about 24-96 hours at below room temperature. In comparison, fibrils may be obtained by limited pepsin digestion achieved at a ratio of about 1:100 (enzyme: collagen) for about 24-96 hours at 4°C.
Collagen fibers obtained according to this methodology are then used to fabricate the prosthetic intervertebral disc of the present invention.
However, it must be appreciated that collagen obtained from other sources, such as biosynthetically-produced collagen or analogs thereof, may also be used in the construction of the prosthetic intervertebral disc.
One method of fabrication includes molding the collagen fibers into a predetermined shape using, for ezample, the mold forms described below in conjunction With FIGS. 6 and 7. The fibers may be placed randomly in the mold, or may be oriented in specific directions to achieve a intervertebral disc having specific structure characteristics. Other components such as GAGs which may participate in the cross-linking reaction, can be mized in with the fibers in a random or non-random fashion before the structure is subjected to various cross-linking procedures including chemical methods and/or dehydrothermal methods.
By following the processes described in the ezamples set forth hereinbelow, a prosthetic intervertebral disc of the form shown in FIGs. 2 or 3 may be constructed having the characteristics listed below in TABLE 1.

WO 91/16867 2 O 8 2 4 ? l PCT/US91/03106 1?hysical Cha~acteristj,cs height A = 5 - 12 mm radius C = 10 - 25 mm density = 0.07 - 0.5 g/cm3 intra- and interfibrillary space = 2 - 25 cm3/g matziz Constituents fiber content = 75 - 100~C
glycosaminoglycan content = 0 - 25~
The prosthetic discs were evaluated ~ v'v and ~ vitro to determine ability to function physically, or to serve as a regeneration template for the fibrochondrocytes ezpected to serve as precursor cells for the subsequent fibrocartilaginous matriz. These studies demonstrate that the prosthetic disc allows for, and induces fibrochondrocyte infiltration and disc regeneration through the prosthetic material.
The following non-limiting ezamples describe methods of fabrication and ~ vivo use of the prosthetic intervertebral disc of the present invention.
FXAMPL~ 1 Mold Fabrication A mold useful for fabricating the prosthetic intervertebral disc is made of implantable stainless steel or biocompatible plastics such as polypropylene, delrin*, or combination of these materials. Exemplary molds 300 and 500 shown in Figures 6 and 7 respectively are composed of three pieces, labelled 302, 304, and 306 in Figure 6 and 502, 504 and 506 in Figure 7.
Hy way of ezample for the disc-shaped intervertebral disc illustrated in FIGS. 5A and 5B, the mold 300 of FIG. 6 is used. Piece 302 is disc-like and has a diameter substantially equal to that of the desired intervertebral disc. Piece 302 is perforated to allow liquid to pass through under pressure. The inner surface 303 of piece 302 has the desired shape of one side of the intervertebral disc-to-be-formed.
Piece 304 is a hollow cylinder which has the same inner dimension as piece 302. Piece 306 is a cylindrical piston which has an outer diameter .
slightly less than the inner diameter of piece 304.
The "top", or crown, surface 308 of piston 306 has the desired shape of one side of the intervertebral disc-to-be-formed.
For an intervertebral disc having flat top and bottom surfaces, the mold 500 of FIG. 7 is used where pieces 502 and 504 are.the same as pieces 302 and 304 in FIG. 6, and piece 506 is similar to piece 306 in FIG. 6 but has a flat crown surface 508.
During fabrication of the prosthetic disc 230, mold piece 302 is first assembled within piece 304, as shown in FIG. 6. The constituent fibers (in a fluid) are placed against the surface 303 of piece * Trade mark wo 9m ~ss~ 2 0 8 2 4 2 7 p~~US91 /03106 302. The crown surface 308 of piston 306 is then driven toward surface 303 along a compression azis until the fibers are compressed, the fluid is driven out through piece 302, and the desired azial dimension of the compressed fiber array is attained.
The mold is then frozen in pzeparation for cross-linking.
FXAMPL~ 2 1~ Pzeparatior. of Furified Type I CollagGr~
Bovine. porcine, or sheep Achilles tendon is obtained from USDA-approved slaughter houses. The preferred age of the animals is between 12 - 18 months. The tissue is kept cold during the purification process ezcept Where specified to minimize bacteria contamination and tissue degradation.
The adhering tissues of carefully selected tendons are first scrapped off mechanically. The tendons are then minced or cut into fine pieces and washed in ezcess quantities (about 10 volumes) of cold Water to remove residual blood proteins and water soluble materials.
The washed tendons are eztracted in ten volumes of 5$ NaCl, 0.01 M Tris, pH 7.4, for 24 (+/-4) hours to remove salt soluble materials. The salt-eztracted tendons are repeatedly washed in about 10 volumes of water to remove the salt.
To eztract lipid, the material is eztracted in 3$ Triton X-100 for 24 (+/- 2) hours. The ~~ 2082427 detergent is removed by extensive washing with water. The material is then extracted in 3-4 volumes of ether-ethanol (1:1 vol/vol) for 24 (+/- 2) hours to further minimize the lipid content. The lipid extracted material is extensively washed in water to remove the ether and ethanol.
The material is then subjected to two extreme pH eztractions to remove non-collagenous r.:aterials. Alkaline extraction is cornucted with 3-4 volumes of 0.2 M NaOH at pH 12.5 - 13.5 at room temperature in the presence of 1.0 M (CH3)NCl for 24 (+/- 2) hours with mild agitation.
Following alkaline extraction, the pH is neutralized with HC1, and the material is washed with Water. The pH is then adjusted to 2.5 - 3.0 by adding concentrated acetic acid to a final concentration of 0.5 M. The acid extraction is continued for 24 (+/- 2) hours with agitation.
The acid swollen tendon is then subjected to a limited proteolytic digestion with pepsin (enzyme:collagen = 1:100) for 24 (+/-) 2 hours. The pepsin and resulting telopeptides are removed through dialysis.
The swollen fibrillar material is then coacervated by adjusting the pH to its isoionic point with 1 M NaOH or HCl or by adjusting the ionic strength to 0.7 with NaCl. The aggregated collagen fibers are harvested by filtration, and the filtered material extensively washed with cold phosphate ffO 91 / 16867 2 0 8 2 4 2 7 P~/US91 /03106 buffered saline solution. The highly purified type I
collagen may be stored at -20 to -40°C until used.

Device I Fabrication A) The collagen content of the highly purified type I collagen fibrils from EXAMPLE 2 is determined either by gravimetric methods or by determining the hydrozyproline content assuming a 13.5~C by weight of hydrozyproline in Type I collagen The amount of purified material needed to fabricate a given density of a prosthetic intervertebral disc device is then determined and weighed out.
B) A solution of fibrillar collagen is carefully fit into a mold of desired, specified dimensions (see EXAMPLE I and FIG. 6 for a description of molds). Collagen fibers are laid down in random manner or in an oriented manner. In the oriented manner, circumferential orientation of the fibers is produced by rotation of the piston about its principal azis as the material is compressed in the mold; radial orientation is produced by manual painting of the collagen fibers in a linear, radially directed fashion.
C) The fibers are frozen at -20°C, turned out of the mold, and thawed at room temperature.
D) The fibers are then resuspended in phosphate buffered saline, put back into the mold in the desired orientation(s), and compressed with the piston.

WO 91/16867 2 0 8 2 4 2 7 P~/US91/03106 E) The compressed fibers are then refrozen at -20°C and then thawed at room temperature.
F) The resulting structure is cross-linked by soaking in a 0.2% glutaraldehyde solution, pH 7.6, for 24 (+/- 0.5) hours. Each glutaraldehyde-cross-linked prosthetic disc is subsequently rinsed repeatedly in 500 ml of phosphate buffered saline (PHS) solution pH 7.4, for 4, 8, 24 and 48 hours.
G) The rinsed matriz is then lyophilized.

Device Fabrication A)-E) (same as EXAMPLE 3) F) The structure is immersed in an aqueous solution of 0.5 M sodium nitrite, 0.3 M Hcl, and Nacl (OM, 0.34 M, 1.0 M, or 1.34 M) for 3 minutes at 4°C.
~XBMPLE 5 Device II Fabrication A)-G) (same as in EXAMPLE 3) H) The lyophilized matriz is subjected to dehydrothermal cross-linking by vacuum and heat. The vacuum is first applied to reduce the residual water content to a minimal level. Some structural Water (about 3%) may still be associated With collagen triple-heliz as part of the structure stabilizing factor. The heat is increasing in steps to 110°C

VVO 91 / 16867 ~ ~ ~ ~ ~ ~ ~ PCT/US91 /03106 (+/- 5°), and continually applied at 110°C under vacuum for 24 (+/- 2) hours.

Device III Fabrication A) (same as in EXAMPLE 3) H) The collagen material is dispersed in 0.01 M HCl at pH 2.0 - 2.5. Predetermined amounts of various GAGS are weighed and dissolved in water. For eaample, for a given density of 0.25 g/cm2, the collagen content will be 0.244 g, the hyaluronic acid content will be 0.003 g, and the chondroitin sulfate content will be 0.003 g for a 2.5~ GAG
content. The GAG solution is mined in with the collagen solution and placed in the mold in the desired orientation as described in EXAMPLE 2.
C)-G) (same as in EXAMPLE 3) Device IV Fabrication A)-C) (same as in EXAMPLE 3) D) (same as in EXAMPLE 3 ezcept that the . fibers laid down are not compressed.
E)-G) (same as in EXAMPLE 3) WO 91/16867 ~ ~ ~ ~ ~ ~ ~ PCT/US91/03106 EXAMPLE 8 v Device V Fabrication A)-E) (same as in EXAMPLE 3) F) The molded collagen is cross-linked in 5~ polyglycerol polyglycidyl ether in 50~C ethanol and 0.1 M Na2C03 at pH 10.0 for 24 (+/- 2) hours. The cross-linked device is rinsed for 4, 8, 24 and 48 ~ 0 hoLIB, A3Cf? ~rTlth 500 ml of PBS, pH ?.4.
G) (same as in EXAMPLE 3) Device VI Fabrication A)-E) (same as in EXAMPLE 3) F) The molded collagen is cross-linked in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (10 mg/g matriz) in 0.9~ NaCl, pH 4.7 at room temperature for 24 (+/- 2) hours. The addition of carbodiimide is made every 3 - 4 hours, and the pH
is adjusted to 4.7 after each addition of carbodiimide.
G) (same as in EXAMPLE 3) W~Q 91 / 16867 2 0 8 2 4 2 7 PCT/US91 /03106 Device VII Fabrication A)-D) (same as in EXAMPLE 2) E) For attachment purposes, a mesh of absorbable polyglyconate suture material, matched to the size of the mold, is laid in the dispersed collagen such that it protrudes from the structure's periphery to form a skirt which may eztend over the vertebral body. This mesh provides both immediate attachment sites and long term fibrous ingrowth.
F)-G) (same as in EXAMPLE 2) 33'~ vitro Testing Intervertebral discs are aseptically harvested from mature goats or dogs, trimmed of all adherent tissue, and placed into Gey's balanced saline solution. Each disc is bisected in the coronal plane and 3 mm full-thickness circular defects are made in each half. The defects are filled With a 3 mm diameter plug of one of two prototypes of a complez collagen-based matriz. The discs are placed in siz well culture plates containing 6 ml of Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum, sodium ascorbate, and 0.1% penicillin/streptomycin.
Cultures are maintained at 37°C in a humidified atmosphere of 10% C02/90% air, fed three times per week, and placed in fresh culture wells every week to prevent the formation of eaplant cell cultures. At WO 91/16867 PC?/US91/03106 = 2082421 intervals of one, four, and sir weeks after initiation of culture, three discs from each group are removed, fired, and evaluated with serial sections and staining. New collagen and glycosaminoglycan formation is evidenced histologically using Alcian Hlue and Masson's Trichrome stains.
The results demonstrate increasing cellular migration and irwasion over time. There is no apparent tozicity from the material. The depth of cellular penetration into the scaffold appears to be limited by the density of the prosthetic complez.
EXAMPL~ 12 In vivo Testing The cervical vertebral disc of a mature goat was primarily ezcised and surgically replaced by a prosthestic disc. The goat returned to full cage activities within a day after surgery. Serial radiographs have documented preservation of the interveztebral joint space.
The present invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
A

Claims (69)

1. A prosthetic intervertebral disc comprising a dry, porous volume matrix of biocompatible and bioresorbable fibers, said matrix being adapted to have in vivo an outer surface contour substantially the same as that of a natural intervertebral disc, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of vertebral fibrochondrocytes, and wherein said scaffold and said ingrown fibrochondrocytes support natural intervertebral disc load forces.
2. The disc of claim 1 wherein said fibers comprise polymers.
3. The disc of claim 1 wherein said fibers are selected from the group consisting of natural polymers, analogs of said natural polymers, synthetic fibers, and mixtures thereof.
4. The disc of claim 3 wherein said natural polymers are selected from the group consisting of collagen, elastin, reticulin, cellulose, analogs thereof, and mixtures thereof.
5. The disc of claim 4 wherein said natural polymers are collagen-based polymers.
6. The disc of claim 1 further comprising cross-links between at least a portion of said fibers.
7. The disc of claim 1 further comprising a plurality of glycosaminoglycan molecules interspersed with said fibers.
8. The disc of claim 7, wherein said glycosaminoglycan molecules are selected from the group consisting of chondroitin 4-sulfate, chondroitin 6-sulfate, keratin sulfate, dermatan sulfate, heparan sulfate, heparin, hyaluronic acid, and mixtures thereof.
9. The disc of claim 7 wherein at least a portion of said molecules provide cross-links between said fibers.
10. The disc of claim 7 wherein said fibers are present at a concentration of 75-100% by dry weight, and said glycosaminoglycan molecules are present at a concentration of 0-25% by dry weight.
11. The prosthetic disc of claim 6 wherein said cross-links are formed by a chemical cross-linking agent.
12. The prosthetic disc of claim 11 wherein said cross-linking agent is selected from the group consisting of glutaraldehyde, formaldehyde, biocompatible bifunctional aldehydes, carbodiimides, hexamethylene diisocyanate, bis-imidates, polyglycerol polyglycidyl ether, glyoxal, acyl azide, and mixtures thereof.
13. The prosthetic disc of claim 12 wherein said cross-linking agent comprises 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide.
14. The disc of claim 1 wherein said intervertebral disc has a density of 0.07 to 0.50 gram matrix per cubic centimeter.
15. The disc of claim 1 wherein said intervertebral disc has an intrafibrillary and interfibrillary space of 2 - 25 cm3/g matrix.
16. The disc of claim 1 wherein said fibers are oriented in a substantially random fashion throughout said matrix.
17. The disc of claim 1 wherein said fibers are oriented in a substantially ordered fashion throughout said matrix.
18. The disc of claim 17 wherein said matrix comprises substantially circumferentially extending fibers.
19. The disc of claim 17 wherein said matrix comprises substantially radially extending fibers.
20. The disc of claim 1 wherein the density of said fibers is substantially uniform throughout said matrix.
21. The disc of claim 1 wherein said fibers are oriented in a substantially ordered fashion in the region adjacent to the peripheral edge of said disc, said orientation being substantially circumferential.
22. The disc of claim 21 wherein said fibers are oriented in a substantially random fashion in the central region of said disc.
23. The disc of claim 7 wherein said glycosaminoglycan molecules are dispersed substantially uniformly throughout said matrix.
24. The disc of claim 7 wherein said glycosaminoglycan molecules are dispersed nonuniformly throughout said matrix.
25. The disc of claim 1 further comprising a mesh extending from a portion of the outer surface of said matrix, said mesh being resorbable and biocompatible.
26. A method for fabricating a prosthetic intervertebral disc comprising the steps of:
(a) placing a plurality of biocompatible and bioresorbable fibers into a mold, said mold having a shape that enables disc space function;
(b) subjecting said fibers to a first and a second cycle of freezing and thawing;
(c) contacting said fibers with a chemical cross-linking agent such that said fibers assume the shape of said mold; and (d) lyophilizing said cross-linked fibers, said prosthetic intervertebral disc thus formed comprising a dry porous volume matrix being adapted to have in vivo an outer surface countour substantially the same as that of a natural intervertebral disc, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of vertebral fibrochondrocytes.
27. The method of claim 26 wherein said placing step comprises placing a plurality of fibers into a mold, said fibers being selected from the group comprising a natural material, an analog thereof, and a synthetic material.
28. The method of claim 27 wherein said analog of said natural material is a biosynthetic analog.
29. The method of claim 26 wherein said placing step further comprises placing a plurality of polymeric fibers into said mold.
30. The method of claim 26 wherein said fibers are selected from the group consisting of collagen, elastin, reticulin, cellulose, analogs thereof, and mixtures thereof.
31. The method of claim 26 wherein said placing step further comprises placing a plurality of glycosaminoglycan molecules into said mold.
32. The method of claim 31 wherein said glycosaminoglycan molecules are selected from the group consisting of chondroitin 4-sulfate, chondroitin 6-sulfate, keratin sulfate, dermatan sulfate, heparin, heparan sulfate, hyaluronic acid, and mixtures thereof.
33. The method of claim 26 wherein said placing step further comprises the step of orienting said fibers substantially circumferentially.
34. The method of claim 33 wherein said orienting step comprises compressing said fibers in said mold with a piston, directed along a compression axis, while during said compressing step said piston is rotated with respect to said mold about said compression axis.
35. The method of claim 33 wherein said orienting step comprises rotating said mold as said fibers are placed therein.
36. The method of claim 26 wherein said placing step further comprises the step of orienting said fibers substantially radially.
37. The method of claim 26 further comprising the step of compressing said fibers prior to said second cycle of freezing and thawing.
38. The method of claim 31 further comprising the step of compressing said fibers and said glycosaminoglycan molecules prior to said second cycle of freezing and thawing.
39. The method of claim 37 wherein said compressing step comprises applying a predetermined amount of pressure to a region of said matrix with a piston, said piston having a predetermined shape.
40. The method of claim 26 wherein said chemical cross-linking agent is selected from the group consisting of glutaraldehyde, formaldehyde, biocompatible and bifunctional aldehydes, carbodiimides, hexamethylene diisocyanate, bis-imidates, polyglycerol polyglycidylether, glyoxal, acyl azide, and mixtures thereof.
41. The method of claim 26 further comprising the additional step of subjecting said lyophilized matrix to dehydrothermal cross-linking.
42. The use of a prosthetic intervertebral disc for regeneration of intervertebral tissue in vivo wherein said disc comprises a dry porous volume matrix of biocompatible and bioresorbable fibers, said matrix being adapted to have in vivo an outer surface contour substantially the same as that of a natural intervertebral disc, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of vertebral fibrochondrocytes, and wherein said scaffold and said ingrown fibrochondrocytes support natural intervertebral disc load forces.
43. The use of claim 42 wherein at least a portion of said fibers are cross-linked.
44. The use of claim 42 wherein a plurality of glycosaminoglycan molecules are interspersed with said fibers.
45. The use of claim 42 wherein said disc further comprises a mesh extending from a portion of the outer surface of said disc, said mesh being resorbable and biocompatible.
46. The use of any one of claims 42 to 45, wherein said fibers are selected from the group consisting of natural polymers, and analogs and mixtures thereof.
47. The disc of claim 1, wherein said fibers are selected from the group consisting of natural polymers, and analogs and mixtures thereof.
48. The disc of claim 47 wherein said natural polymers are selected from the group consisting of collagen, elastin, reticulin, cellulose, analogs thereof, and mixtures thereof.
49. The disc of claim 48 wherein said natural polymers are collagen-based polymers.
50. The disc of claim 47 further comprising cross-links between at least a portion of said fibers.
51. The disc of claim 47 further comprising a plurality of glycosaminoglycan molecules interspersed with said fibers.
52. The disc of claim 51, wherein said glycosaminoglycan molecules are selected from the group consisting of chondroitin 4-sulfate, chondroitin 6-sulfate, keratin sulfate, dermatan sulfate, heparan sulfate, heparin, hyaluronic acid, and mixtures thereof.
53. The disc of claim 51 wherein at least a portion of said molecules provide cross-links between said fibers.
54. The disc of claim 51 wherein said fibers are present at a concentration of 75-100% by dry weight, and said glycosaminoglycan molecules are present at a concentration of 0-25% by dry weight.
55. The prosthetic disc of claim 50 wherein said cross-links are formed by a chemical cross-linking agent.
56. The prosthetic disc of claim 55 wherein said cross-linking agent is selected from the group consisting of glutaraldehyde, formaldehyde, biocompatible bifunctional aldehydes, carbodiimides, hexamethylene diisocyanate, bis-imidates, polyglycerol polyglycidyl ether, glyoxal, acyl azide, and mixtures thereof.
57. The prosthetic disc of claim 56 wherein said cross-linking agent comprises 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide.
58. The disc of claim 47 wherein said intervertebral disc has a density of 0.07 to 0.50 gram matrix per cubic centimeter.
59. The disc of claim 47 wherein said intervertebral disc has an intrafibrillary and interfibrillary space of 2 - 25 cm3/g matrix.
60. The disc of claim 47 wherein said fibers are oriented in a substantially random fashion throughout said matrix.
61. The disc of claim 47 wherein said fibers are oriented in a substantially ordered fashion throughout said matrix.
62. The disc of claim 61 wherein said matrix comprises substantially circumferentially extending fibers.
63. The disc of claim 61 wherein said matrix comprises substantially radially extending fibers.
64. The disc of claim 47 wherein the density of said fibers is substantially uniform throughout said matrix.
65. The disc of claim 47 wherein said fibers are oriented in a substantially ordered fashion in the region adjacent to the peripheral edge of said disc, said orientation being substantially circumferential.
66. The disc of claim 65 wherein said fibers are oriented in a substantially random fashion in the central region of said disc.
67. The disc of claim 51 wherein said glycosaminoglycan molecules are dispersed substantially uniformly throughout said matrix.
68. The disc of claim 51 wherein said glycosaminoglycan molecules are dispersed nonuniformly throughout said matrix.
69. The disc of claim 47 further comprising a mesh extending from a portion of the outer surface of said matrix, said mesh being resorbable and biocompatible.
CA 2082427 1989-03-02 1991-05-06 Prosthetic intervertebral disc Expired - Lifetime CA2082427C (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US520,027 1990-05-07
US07520027 US5108438A (en) 1989-03-02 1990-05-07 Prosthetic intervertebral disc
PCT/US1991/003106 WO1991016867A1 (en) 1990-05-07 1991-05-06 Prosthetic intervertebral disc

Publications (2)

Publication Number Publication Date
CA2082427A1 true CA2082427A1 (en) 1991-11-08
CA2082427C true CA2082427C (en) 2000-10-31

Family

ID=24070896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2082427 Expired - Lifetime CA2082427C (en) 1989-03-02 1991-05-06 Prosthetic intervertebral disc

Country Status (6)

Country Link
US (1) US5108438A (en)
EP (1) EP0527936B1 (en)
JP (1) JP3162375B2 (en)
CA (1) CA2082427C (en)
DE (2) DE69126971T2 (en)
WO (1) WO1991016867A1 (en)

Families Citing this family (269)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306311A (en) * 1987-07-20 1994-04-26 Regen Corporation Prosthetic articular cartilage
US5735902A (en) * 1987-07-20 1998-04-07 Regen Biologics, Inc. Hand implant device
US5263984A (en) * 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
US5269785A (en) * 1990-06-28 1993-12-14 Bonutti Peter M Apparatus and method for tissue removal
US6503277B2 (en) * 1991-08-12 2003-01-07 Peter M. Bonutti Method of transplanting human body tissue
DE4220218C2 (en) * 1992-06-20 1994-09-22 S & G Implants Gmbh Implant with an open-cell or open-cell metal structure
WO1995006439A1 (en) * 1993-08-31 1995-03-09 Depuy Inc. Catgut orthopaedic appliance
US5514180A (en) * 1994-01-14 1996-05-07 Heggeness; Michael H. Prosthetic intervertebral devices
EP0751751A4 (en) * 1994-03-22 1998-03-25 Organogenesis Inc Three-dimensional bioremodelable collagen fabrics
US5571189A (en) * 1994-05-20 1996-11-05 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
US5674296A (en) 1994-11-14 1997-10-07 Spinal Dynamics Corporation Human spinal disc prosthesis
US5713374A (en) * 1995-02-10 1998-02-03 The Hospital For Joint Diseases Orthopaedic Institute Fixation method for the attachment of wound repair materials to cartilage defects
US6080194A (en) * 1995-02-10 2000-06-27 The Hospital For Joint Disease Orthopaedic Institute Multi-stage collagen-based template or implant for use in the repair of cartilage lesions
US6262255B1 (en) 1995-04-05 2001-07-17 Biomm, Inc. Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them
US5645597A (en) * 1995-12-29 1997-07-08 Krapiva; Pavel I. Disc replacement method and apparatus
US5865845A (en) * 1996-03-05 1999-02-02 Thalgott; John S. Prosthetic intervertebral disc
US5964807A (en) * 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
DE19710392C1 (en) * 1997-03-13 1999-07-01 Haehnel Michael Slipped disc implant comprises an extensible, hinged or wound body
US6017366A (en) * 1997-04-18 2000-01-25 W. L. Gore & Associates, Inc. Resorbable interposition arthroplasty implant
GB9713330D0 (en) * 1997-06-25 1997-08-27 Bridport Gundry Plc Surgical implant
US6241771B1 (en) * 1997-08-13 2001-06-05 Cambridge Scientific, Inc. Resorbable interbody spinal fusion devices
DE69714035D1 (en) * 1997-08-14 2002-08-22 Sulzer Innotec Ag Composition and apparatus for the repair of cartilage tissue in vivo comprising nanocapsules with osteoinductive and / or chondroinductive factors
EP1009339A1 (en) 1997-08-28 2000-06-21 Franz K. Fuss Prosthesis of the spinal column
US6482233B1 (en) 1998-01-29 2002-11-19 Synthes(U.S.A.) Prosthetic interbody spacer
US6241769B1 (en) 1998-05-06 2001-06-05 Cortek, Inc. Implant for spinal fusion
US6296664B1 (en) * 1998-06-17 2001-10-02 Surgical Dynamics, Inc. Artificial intervertebral disc
US6086593A (en) 1998-06-30 2000-07-11 Bonutti; Peter M. Method and apparatus for use in operating on a bone
CA2338379A1 (en) 1998-07-22 2000-02-03 Spinal Dynamics Corporation Threaded cylindrical multidiscoid single or multiple array disc prosthesis
US6099531A (en) 1998-08-20 2000-08-08 Bonutti; Peter M. Changing relationship between bones
CA2342633C (en) * 1998-09-04 2007-11-13 Spinal Dynamics Corporation Peanut spectacle multi discoid thoraco-lumbar disc prosthesis
DE19855890A1 (en) * 1998-12-03 2000-06-08 Nerlich Michael Porous composite matrix, their preparation and use
US6206923B1 (en) * 1999-01-08 2001-03-27 Sdgi Holdings, Inc. Flexible implant using partially demineralized bone
CA2363254C (en) 1999-03-07 2009-05-05 Discure Ltd. Method and apparatus for computerized surgery
US6969404B2 (en) * 1999-10-08 2005-11-29 Ferree Bret A Annulus fibrosis augmentation methods and apparatus
US20070038231A1 (en) * 1999-05-28 2007-02-15 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US7273497B2 (en) * 1999-05-28 2007-09-25 Anova Corp. Methods for treating a defect in the annulus fibrosis
US20060247665A1 (en) 1999-05-28 2006-11-02 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US6632651B1 (en) 1999-07-06 2003-10-14 Ramot At Tel Aviv University Ltd. Tissue maintenance system that applies rhythmic pulses of pressure
US6652872B2 (en) 1999-07-06 2003-11-25 Ramat At Tel Aviv University Ltd. Scaffold formed of tissue treated to eliminate cellular and cytosolic elements
US7435260B2 (en) * 1999-08-13 2008-10-14 Ferree Bret A Use of morphogenetic proteins to treat human disc disease
US6645247B2 (en) * 1999-10-08 2003-11-11 Bret A. Ferree Supplementing engineered annulus tissues with autograft of allograft tendons
US6648920B2 (en) * 1999-10-08 2003-11-18 Bret A. Ferree Natural and synthetic supplements to engineered annulus and disc tissues
US6685695B2 (en) * 1999-08-13 2004-02-03 Bret A. Ferree Method and apparatus for providing nutrition to intervertebral disc tissue
US6793677B2 (en) * 1999-08-13 2004-09-21 Bret A. Ferree Method of providing cells and other biologic materials for transplantation
US20040186573A1 (en) * 1999-10-08 2004-09-23 Ferree Bret A. Annulus fibrosis augmentation methods and apparatus
US6454804B1 (en) 1999-10-08 2002-09-24 Bret A. Ferree Engineered tissue annulus fibrosis augmentation methods and apparatus
US20030026788A1 (en) * 1999-10-08 2003-02-06 Ferree Bret A. Use of extracellular matrix tissue to preserve cultured cell phenotype
US20030004574A1 (en) * 1999-10-08 2003-01-02 Ferree Bret A. Disc and annulus augmentation using biologic tissue
US7220281B2 (en) * 1999-08-18 2007-05-22 Intrinsic Therapeutics, Inc. Implant for reinforcing and annulus fibrosis
US20040024465A1 (en) 1999-08-18 2004-02-05 Gregory Lambrecht Devices and method for augmenting a vertebral disc
EP1624832A4 (en) 1999-08-18 2008-12-24 Intrinsic Therapeutics Inc Devices and method for augmenting a vertebral disc nucleus
US6936072B2 (en) * 1999-08-18 2005-08-30 Intrinsic Therapeutics, Inc. Encapsulated intervertebral disc prosthesis and methods of manufacture
US6425919B1 (en) 1999-08-18 2002-07-30 Intrinsic Orthopedics, Inc. Devices and methods of vertebral disc augmentation
US7553329B2 (en) * 1999-08-18 2009-06-30 Intrinsic Therapeutics, Inc. Stabilized intervertebral disc barrier
US7998213B2 (en) 1999-08-18 2011-08-16 Intrinsic Therapeutics, Inc. Intervertebral disc herniation repair
WO2002054978A3 (en) 1999-08-18 2002-11-07 Intrinsic Therapeutics, Inc. Devices and method for nucleus pulposus augmentation and retention
US7717961B2 (en) 1999-08-18 2010-05-18 Intrinsic Therapeutics, Inc. Apparatus delivery in an intervertebral disc
US6783546B2 (en) * 1999-09-13 2004-08-31 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6755863B2 (en) * 1999-10-08 2004-06-29 Bret A. Ferree Rotator cuff repair using engineered tissues
US7201776B2 (en) * 1999-10-08 2007-04-10 Ferree Bret A Artificial intervertebral disc replacements with endplates
US6419704B1 (en) 1999-10-08 2002-07-16 Bret Ferree Artificial intervertebral disc replacement methods and apparatus
US7060100B2 (en) * 1999-10-08 2006-06-13 Ferree Bret A Artificial disc and joint replacements with modular cushioning components
US7201774B2 (en) * 1999-10-08 2007-04-10 Ferree Bret A Artificial intervertebral disc replacements incorporating reinforced wall sections
US20040172019A1 (en) * 1999-10-08 2004-09-02 Ferree Bret A. Reinforcers for artificial disc replacement methods and apparatus
US6648919B2 (en) * 1999-10-14 2003-11-18 Bret A. Ferree Transplantation of engineered meniscus tissue to the intervertebral disc
EP1974698A3 (en) 1999-10-20 2009-01-28 Anulex Technologies, Inc. Spinal disc annulus stent
US20030153976A1 (en) 1999-10-20 2003-08-14 Cauthen Joseph C. Spinal disc annulus reconstruction method and spinal disc annulus stent
US6592625B2 (en) 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US8163022B2 (en) 2008-10-14 2012-04-24 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
WO2001028464A1 (en) 1999-10-20 2001-04-26 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US7951201B2 (en) 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7615076B2 (en) 1999-10-20 2009-11-10 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7052516B2 (en) 1999-10-20 2006-05-30 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US8128698B2 (en) 1999-10-20 2012-03-06 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7004970B2 (en) 1999-10-20 2006-02-28 Anulex Technologies, Inc. Methods and devices for spinal disc annulus reconstruction and repair
US8632590B2 (en) 1999-10-20 2014-01-21 Anulex Technologies, Inc. Apparatus and methods for the treatment of the intervertebral disc
US7935147B2 (en) 1999-10-20 2011-05-03 Anulex Technologies, Inc. Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus
DE60033055D1 (en) * 1999-12-06 2007-03-08 Warsaw Orthopedic Inc Intervertebral disc treatment device
US6740093B2 (en) * 2000-02-28 2004-05-25 Stephen Hochschuler Method and apparatus for treating a vertebral body
US6805695B2 (en) 2000-04-04 2004-10-19 Spinalabs, Llc Devices and methods for annular repair of intervertebral discs
US6723335B1 (en) * 2000-04-07 2004-04-20 Jeffrey William Moehlenbruck Methods and compositions for treating intervertebral disc degeneration
US20080086133A1 (en) * 2003-05-16 2008-04-10 Spineology Expandable porous mesh bag device and methods of use for reduction, filling, fixation and supporting of bone
US20020068974A1 (en) * 2000-07-21 2002-06-06 Kuslich Stephen D. Expandable porous mesh bag device and methods of use for reduction, filling, fixation and supporting of bone
US6638312B2 (en) 2000-08-04 2003-10-28 Depuy Orthopaedics, Inc. Reinforced small intestinal submucosa (SIS)
US8366787B2 (en) 2000-08-04 2013-02-05 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
US6562045B2 (en) 2001-02-13 2003-05-13 Sdgi Holdings, Inc. Machining apparatus
US7601174B2 (en) * 2000-08-08 2009-10-13 Warsaw Orthopedic, Inc. Wear-resistant endoprosthetic devices
JP2004516044A (en) 2000-08-08 2004-06-03 エスディージーアイ・ホールディングス・インコーポレーテッド Improved methods and apparatus of the stereotactic implantation
JP4617408B2 (en) * 2000-08-08 2011-01-26 ワルシャワ オーソピディック、インク. Implantable artificial joints
US7226480B2 (en) * 2000-08-15 2007-06-05 Depuy Spine, Inc. Disc prosthesis
US6458159B1 (en) * 2000-08-15 2002-10-01 John S. Thalgott Disc prosthesis
DE60139262D1 (en) * 2000-08-28 2009-08-27 Disc Dynamics Inc System for recovery of joint surfaces of mammals
US7503936B2 (en) * 2000-08-30 2009-03-17 Warsaw Orthopedic, Inc. Methods for forming and retaining intervertebral disc implants
ES2303972T3 (en) 2000-08-30 2008-09-01 Warsaw Orthopedic, Inc. Intervertebral disc implants.
US7204851B2 (en) * 2000-08-30 2007-04-17 Sdgi Holdings, Inc. Method and apparatus for delivering an intervertebral disc implant
US6620196B1 (en) 2000-08-30 2003-09-16 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US20050154463A1 (en) * 2000-08-30 2005-07-14 Trieu Hal H. Spinal nucleus replacement implants and methods
US20020026244A1 (en) * 2000-08-30 2002-02-28 Trieu Hai H. Intervertebral disc nucleus implants and methods
DE60128933T2 (en) 2000-09-18 2008-02-14 Organogenesis, Inc., Canton A method for treating a patient with a cultured connective tissue construct
EP1832300A3 (en) * 2000-09-18 2008-02-27 Organogenesis Inc. Method for treating a patient using a cultured connective tissue construct
US6733531B1 (en) 2000-10-20 2004-05-11 Sdgi Holdings, Inc. Anchoring devices and implants for intervertebral disc augmentation
EP1328222B1 (en) * 2000-10-27 2005-03-30 SDGI Holdings, Inc. Annulus repair system
US6632235B2 (en) * 2001-04-19 2003-10-14 Synthes (U.S.A.) Inflatable device and method for reducing fractures in bone and in treating the spine
US6770075B2 (en) 2001-05-17 2004-08-03 Robert S. Howland Spinal fixation apparatus with enhanced axial support and methods for use
US20060064092A1 (en) * 2001-05-17 2006-03-23 Howland Robert S Selective axis serrated rod low profile spinal fixation system
US20040243128A1 (en) * 2001-05-17 2004-12-02 Howland Robert S. Selective axis posterior lumbar spinal plating fixation apparatus and methods for use
US7314467B2 (en) * 2002-04-24 2008-01-01 Medical Device Advisory Development Group, Llc. Multi selective axis spinal fixation system
US20090234457A1 (en) * 2001-06-29 2009-09-17 The Regents Of The University Of California Systems, devices and methods for treatment of intervertebral disorders
US7156877B2 (en) * 2001-06-29 2007-01-02 The Regents Of The University Of California Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs
JP4294474B2 (en) * 2001-07-16 2009-07-15 デピュイ・プロダクツ・インコーポレイテッド Meniscal reproducing apparatus
US7163563B2 (en) * 2001-07-16 2007-01-16 Depuy Products, Inc. Unitary surgical device and method
EP1416886A4 (en) * 2001-07-16 2007-04-18 Depuy Products Inc Cartilage repair and regeneration scaffold and method
WO2003007805A3 (en) * 2001-07-16 2004-02-12 Depuy Products Inc Cartilage repair apparatus and method
US7819918B2 (en) * 2001-07-16 2010-10-26 Depuy Products, Inc. Implantable tissue repair device
US8337537B2 (en) 2001-07-16 2012-12-25 Depuy Products, Inc. Device from naturally occurring biologically derived materials
US7201917B2 (en) * 2001-07-16 2007-04-10 Depuy Products, Inc. Porous delivery scaffold and method
US8025896B2 (en) * 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
JP2005515802A (en) * 2001-07-16 2005-06-02 デピュイ・プロダクツ・インコーポレイテッド Hybrid biological / synthetic type porous extracellular matrix scaffold
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
JP4955388B2 (en) * 2001-08-31 2012-06-20 ユニヴァーシティー オブ サザン カリフォルニア Crosslinking reagents for the treatment of spinal disc disease
US8119599B2 (en) * 2001-08-31 2012-02-21 Orthopeutics, L.P. Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
US7025787B2 (en) * 2001-11-26 2006-04-11 Sdgi Holdings, Inc. Implantable joint prosthesis and associated instrumentation
WO2003049669A3 (en) * 2001-12-10 2004-03-11 Colbar R & D Ltd Methods, devices, and preparations for intervertebral disc treatment
US7232802B2 (en) 2001-12-21 2007-06-19 Zimmer Orthobiologics, Inc. Compositions and methods for promoting myocardial and peripheral angiogenesis
US20060129242A1 (en) * 2001-12-28 2006-06-15 Brian Bergeron Pseudo arthrosis device
US6736850B2 (en) * 2001-12-28 2004-05-18 Spinal Concepts, Inc. Vertebral pseudo arthrosis device and method
US6761723B2 (en) * 2002-01-14 2004-07-13 Dynamic Spine, Inc. Apparatus and method for performing spinal surgery
US20030220692A1 (en) * 2002-02-09 2003-11-27 Shapiro Irving M. Preparations of nucleus pulposus cells and methods for their generation, identification, and use
CA2478581C (en) * 2002-02-19 2010-01-19 Synthes (U.S.A.) Intervertebral implant
US8388684B2 (en) * 2002-05-23 2013-03-05 Pioneer Signal Technology, Inc. Artificial disc device
US7001433B2 (en) * 2002-05-23 2006-02-21 Pioneer Laboratories, Inc. Artificial intervertebral disc device
US20040049283A1 (en) * 2002-06-04 2004-03-11 Tushar Patel Medical implant and method of reducing back pain
EP1545401A4 (en) * 2002-06-14 2006-09-27 Crosscart Inc Galactosidase-treated prosthetic devices
US7622562B2 (en) * 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US6958078B2 (en) * 2002-08-19 2005-10-25 The University Of Toledo Bioartificial intervertebral disc
US20040054414A1 (en) * 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
US7744651B2 (en) * 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
KR101095771B1 (en) * 2002-09-18 2011-12-21 워쏘우 오르쏘페딕 인코포레이티드 Natural tissue devices and methods of implantation
JP2006515765A (en) * 2002-11-15 2006-06-08 エスディージーアイ・ホールディングス・インコーポレーテッド Collagen-based materials and methods for the treatment of synovial joint
JP2007521843A (en) 2003-05-15 2007-08-09 バイオメリクス コーポレーション Reticulated elastomeric matrix, their preparation and use in implantable devices
US6966929B2 (en) * 2002-10-29 2005-11-22 St. Francis Medical Technologies, Inc. Artificial vertebral disk replacement implant with a spacer
US7497859B2 (en) * 2002-10-29 2009-03-03 Kyphon Sarl Tools for implanting an artificial vertebral disk
US7083649B2 (en) * 2002-10-29 2006-08-01 St. Francis Medical Technologies, Inc. Artificial vertebral disk replacement implant with translating pivot point
US7273496B2 (en) * 2002-10-29 2007-09-25 St. Francis Medical Technologies, Inc. Artificial vertebral disk replacement implant with crossbar spacer and method
US20040133278A1 (en) * 2002-10-31 2004-07-08 Marino James F. Spinal disc implant
CA2735334A1 (en) * 2002-11-05 2004-05-21 Spineology, Inc. A semi-biological intervertebral disc replacement system
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
US6974479B2 (en) * 2002-12-10 2005-12-13 Sdgi Holdings, Inc. System and method for blocking and/or retaining a prosthetic spinal implant
US20040210310A1 (en) * 2002-12-10 2004-10-21 Trieu Hai H. Implant system and method for intervertebral disc augmentation
KR20050092795A (en) * 2003-01-31 2005-09-22 짐머 오르쏘바이올로직스 인코포레이티드 Hydrogel compositions comprisign nucleus pulposus tissue
EP2457541A1 (en) 2003-02-06 2012-05-30 Synthes GmbH Implant between vertebrae
US7364589B2 (en) * 2003-02-12 2008-04-29 Warsaw Orthopedic, Inc. Mobile bearing articulating disc
US20040260300A1 (en) * 2003-06-20 2004-12-23 Bogomir Gorensek Method of delivering an implant through an annular defect in an intervertebral disc
EP1638485B1 (en) * 2003-06-20 2011-03-02 Intrinsic Therapeutics, Inc. Device for delivering an implant through an annular defect in an intervertebral disc
US7819880B2 (en) * 2003-06-30 2010-10-26 Depuy Products, Inc. Implant delivery instrument
US7559941B2 (en) * 2003-06-30 2009-07-14 Depuy Products, Inc. Instrument for delivery of implant
US7473259B2 (en) 2003-06-30 2009-01-06 Depuy Products, Inc. Implant stabilizing instrument, kit and method
US7563266B2 (en) * 2003-06-30 2009-07-21 Depuy Products, Inc. Slide and kit for delivering implants
US7753958B2 (en) 2003-08-05 2010-07-13 Gordon Charles R Expandable intervertebral implant
US8118869B2 (en) 2006-03-08 2012-02-21 Flexuspine, Inc. Dynamic interbody device
US7799082B2 (en) * 2003-08-05 2010-09-21 Flexuspine, Inc. Artificial functional spinal unit system and method for use
US7909869B2 (en) 2003-08-05 2011-03-22 Flexuspine, Inc. Artificial spinal unit assemblies
WO2005013852A3 (en) * 2003-08-07 2006-01-12 Dynamic Spine Inc Intervertebral prosthetic device and associated devices and methods for implanting the intervertebral prosthetic device
US7309359B2 (en) * 2003-08-21 2007-12-18 Warsaw Orthopedic, Inc. Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs
EP1523963B1 (en) * 2003-10-17 2007-12-12 Co-Ligne AG Fusion implant
US7651682B2 (en) * 2003-10-29 2010-01-26 Gentis, Inc. Polymerizable emulsions for tissue engineering
US7520899B2 (en) * 2003-11-05 2009-04-21 Kyphon Sarl Laterally insertable artificial vertebral disk replacement implant with crossbar spacer
US20050149192A1 (en) * 2003-11-20 2005-07-07 St. Francis Medical Technologies, Inc. Intervertebral body fusion cage with keels and implantation method
US7837732B2 (en) * 2003-11-20 2010-11-23 Warsaw Orthopedic, Inc. Intervertebral body fusion cage with keels and implantation methods
US7691146B2 (en) * 2003-11-21 2010-04-06 Kyphon Sarl Method of laterally inserting an artificial vertebral disk replacement implant with curved spacer
US20050283237A1 (en) * 2003-11-24 2005-12-22 St. Francis Medical Technologies, Inc. Artificial spinal disk replacement device with staggered vertebral body attachments
US7503935B2 (en) 2003-12-02 2009-03-17 Kyphon Sarl Method of laterally inserting an artificial vertebral disk replacement with translating pivot point
US20050209603A1 (en) * 2003-12-02 2005-09-22 St. Francis Medical Technologies, Inc. Method for remediation of intervertebral disks
US7217291B2 (en) 2003-12-08 2007-05-15 St. Francis Medical Technologies, Inc. System and method for replacing degenerated spinal disks
US20050143826A1 (en) * 2003-12-11 2005-06-30 St. Francis Medical Technologies, Inc. Disk repair structures with anchors
US7763077B2 (en) * 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US20050187631A1 (en) * 2004-01-27 2005-08-25 Sdgi Holdings, Inc. Prosthetic device
US20050165487A1 (en) * 2004-01-28 2005-07-28 Muhanna Nabil L. Artificial intervertebral disc
US7485145B2 (en) * 2004-02-23 2009-02-03 Alphatec Spine, Incorporated Artificial intervertebral disc assembly
ES2537030T3 (en) 2004-03-17 2015-06-01 Revivicor, Inc. Products derived from animal tissue that lack any expression of functional alpha-1,3-galactosyltransferase
US20080306595A1 (en) * 2004-03-26 2008-12-11 Pearsalls Limited Porous Implant For Spinal Disc Nucleus Replacement
EP1732479B1 (en) * 2004-03-26 2011-04-27 NuVasive, Inc. Prosthetic spinal disc
US7569233B2 (en) * 2004-05-04 2009-08-04 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
US20050249772A1 (en) * 2004-05-04 2005-11-10 Prasanna Malaviya Hybrid biologic-synthetic bioabsorbable scaffolds
WO2005112833A1 (en) * 2004-05-20 2005-12-01 Pearsalls Limited Improvements in and relating to surgical implants
US20050273172A1 (en) * 2004-06-07 2005-12-08 Patil Arun A Artificial disc and uses therefor
DE102004041354A1 (en) * 2004-08-25 2006-03-30 Buck, Alfred Implant for surgical use in humans or vertebrates
US7799081B2 (en) * 2004-09-14 2010-09-21 Aeolin, Llc System and method for spinal fusion
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US7303074B2 (en) * 2004-09-22 2007-12-04 Dombrowski Trudy M Foldable organizer device
US20060069438A1 (en) * 2004-09-29 2006-03-30 Zucherman James F Multi-piece artificial spinal disk replacement device with multi-segmented support plates
US7481840B2 (en) * 2004-09-29 2009-01-27 Kyphon Sarl Multi-piece artificial spinal disk replacement device with selectably positioning articulating element
US7575600B2 (en) * 2004-09-29 2009-08-18 Kyphon Sarl Artificial vertebral disk replacement implant with translating articulation contact surface and method
US20060089719A1 (en) * 2004-10-21 2006-04-27 Trieu Hai H In situ formation of intervertebral disc implants
US20060095048A1 (en) * 2004-10-29 2006-05-04 Zannis Anthony D Method of repairing soft tissue using sizing templates
US7513866B2 (en) * 2004-10-29 2009-04-07 Depuy Products, Inc. Intestine processing device and associated method
US7785332B2 (en) * 2004-10-29 2010-08-31 Depuy Products, Inc. Method of delivering therapeutic implant
EP1807007A4 (en) 2004-10-29 2014-03-19 Depuy Products Inc Coordinate instrument set
US7354627B2 (en) * 2004-12-22 2008-04-08 Depuy Products, Inc. Method for organizing the assembly of collagen fibers and compositions formed therefrom
US20060200245A1 (en) * 2005-03-07 2006-09-07 Sdgi Holdings, Inc. Materials, devices, and methods for in-situ formation of composite intervertebral implants
WO2006113586A3 (en) * 2005-04-15 2007-09-20 Musculoskeletal Transplant Vertebral disc repair
WO2006133130A3 (en) * 2005-06-03 2007-04-19 Alan Rory Mcleod Fibrous spinal implant and method of implantation
GB0514891D0 (en) * 2005-07-20 2005-08-24 Pearsalls Ltd Improvements in and relating to implants
US7595062B2 (en) 2005-07-28 2009-09-29 Depuy Products, Inc. Joint resurfacing orthopaedic implant and associated method
GB0516846D0 (en) * 2005-08-17 2005-09-21 Knight David P Meniscal repair device
US20070112360A1 (en) * 2005-11-15 2007-05-17 Patrick De Deyne Bioprosthetic device
US7972337B2 (en) 2005-12-28 2011-07-05 Intrinsic Therapeutics, Inc. Devices and methods for bone anchoring
US20070179618A1 (en) * 2006-01-31 2007-08-02 Sdgi Holdings, Inc. Intervertebral prosthetic disc
CN101478934B (en) 2006-04-28 2012-08-08 香港大学 Bioengineered intervertebral discs and methods for their preparation
US8764835B2 (en) 2006-06-13 2014-07-01 Bret A. Ferree Intervertebral disc treatment methods and apparatus
US9232938B2 (en) 2006-06-13 2016-01-12 Anova Corp. Method and apparatus for closing fissures in the annulus fibrosus
US8834496B2 (en) 2006-06-13 2014-09-16 Bret A. Ferree Soft tissue repair methods and apparatus
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
US20080004703A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc. Method of treating a patient using a collagen material
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
WO2008013763A3 (en) * 2006-07-25 2008-06-26 Morris L Jacobs Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation
US8048618B2 (en) * 2006-07-26 2011-11-01 The University Of Hong Kong Method for preparing and preserving a natural allograft intervertebral disk for humans
US20080026032A1 (en) * 2006-07-27 2008-01-31 Zubery Yuval Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
WO2008033501A3 (en) * 2006-09-14 2008-05-08 Karen Roche Absorbent fabric implant
US8715350B2 (en) 2006-09-15 2014-05-06 Pioneer Surgical Technology, Inc. Systems and methods for securing an implant in intervertebral space
WO2008034135A3 (en) 2006-09-15 2008-07-24 Pioneer Surgical Tech Inc Joint arthroplasty devices having articulating members
US8066750B2 (en) 2006-10-06 2011-11-29 Warsaw Orthopedic, Inc Port structures for non-rigid bone plates
US7871440B2 (en) * 2006-12-11 2011-01-18 Depuy Products, Inc. Unitary surgical device and method
US7905922B2 (en) 2006-12-20 2011-03-15 Zimmer Spine, Inc. Surgical implant suitable for replacement of an intervertebral disc
US8377098B2 (en) * 2007-01-19 2013-02-19 Flexuspine, Inc. Artificial functional spinal unit system and method for use
US7942104B2 (en) * 2007-01-22 2011-05-17 Nuvasive, Inc. 3-dimensional embroidery structures via tension shaping
US7946236B2 (en) * 2007-01-31 2011-05-24 Nuvasive, Inc. Using zigzags to create three-dimensional embroidered structures
WO2008098125A3 (en) * 2007-02-08 2008-11-06 Alan Mcleod Medical implants with pre-settled cores and related methods
EP2679672B1 (en) 2007-07-12 2016-11-30 Discgenics Human disc tissue
US8282681B2 (en) * 2007-08-13 2012-10-09 Nuvasive, Inc. Bioresorbable spinal implant and related methods
US20110196492A1 (en) 2007-09-07 2011-08-11 Intrinsic Therapeutics, Inc. Bone anchoring systems
US8323341B2 (en) 2007-09-07 2012-12-04 Intrinsic Therapeutics, Inc. Impaction grafting for vertebral fusion
US8162994B2 (en) * 2007-10-22 2012-04-24 Flexuspine, Inc. Posterior stabilization system with isolated, dual dampener systems
US8157844B2 (en) * 2007-10-22 2012-04-17 Flexuspine, Inc. Dampener system for a posterior stabilization system with a variable length elongated member
US8267965B2 (en) * 2007-10-22 2012-09-18 Flexuspine, Inc. Spinal stabilization systems with dynamic interbody devices
US8182514B2 (en) * 2007-10-22 2012-05-22 Flexuspine, Inc. Dampener system for a posterior stabilization system with a fixed length elongated member
US8187330B2 (en) 2007-10-22 2012-05-29 Flexuspine, Inc. Dampener system for a posterior stabilization system with a variable length elongated member
US8523912B2 (en) * 2007-10-22 2013-09-03 Flexuspine, Inc. Posterior stabilization systems with shared, dual dampener systems
US8556949B2 (en) 2007-11-14 2013-10-15 DePuy Synthes Products, LLC Hybrid bone fixation element and methods of using the same
US8540774B2 (en) 2007-11-16 2013-09-24 DePuy Synthes Products, LLC Low profile intervertebral implant
JP2011516122A (en) * 2008-03-28 2011-05-26 スパイノロジー インコーポレイテッドSpineology,Inc. Fusion method and apparatus of the spinous process
US8377135B1 (en) 2008-03-31 2013-02-19 Nuvasive, Inc. Textile-based surgical implant and related methods
JP2011519637A (en) * 2008-05-05 2011-07-14 スパイナルモーション, インコーポレイテッド Polyaryletherketone artificial disc
DE102008042401A1 (en) 2008-09-26 2010-04-08 Forschungszentrum Karlsruhe Gmbh Intervertebral disk implant for use between vertebras of spinal column of humans and vertebrate animals, has support component comprising flexible core and biocompatible matrix layer, which is formed with tissue cells
WO2010054181A1 (en) 2008-11-07 2010-05-14 Synthes Usa, Llc Vertebral interbody spacer and coupled plate assembly
US7805920B2 (en) * 2008-11-13 2010-10-05 The Toro Company Lawn mower having steeply inclined exit tunnel and battery access through rear face of mower cutting deck
WO2010062971A9 (en) 2008-11-26 2010-10-07 Anova Corporation Methods and apparatus for anulus repair
US8216316B2 (en) 2008-12-17 2012-07-10 X-Spine Systems, Inc. Prosthetic implant with biplanar angulation and compound angles
US8157865B2 (en) * 2009-01-22 2012-04-17 Stephen Hochschuler Apparatus and method for stabilizing adjacent bone portions
WO2010129692A1 (en) 2009-05-05 2010-11-11 Cornell University Composite tissue-engineered intervertebral disc with self-assembled annular alignment
US8652153B2 (en) 2010-01-11 2014-02-18 Anulex Technologies, Inc. Intervertebral disc annulus repair system and bone anchor delivery tool
US8353964B2 (en) 2010-11-04 2013-01-15 Carpenter Clyde T Anatomic total disc replacement
EP2654626B1 (en) 2010-12-21 2016-02-24 Synthes GmbH Intervertebral implants and systems
US9241809B2 (en) 2010-12-21 2016-01-26 DePuy Synthes Products, Inc. Intervertebral implants, systems, and methods of use
US8388687B2 (en) 2011-03-25 2013-03-05 Flexuspine, Inc. Interbody device insertion systems and methods
KR101273204B1 (en) * 2011-08-22 2013-06-11 주식회사 셀루메드 Methof for producing a composition for inducing of bone formation
US9526627B2 (en) 2011-11-17 2016-12-27 Exactech, Inc. Expandable interbody device system and method
WO2013096249A1 (en) * 2011-12-20 2013-06-27 Lifecell Corporation Sheet tissue products
WO2013096252A1 (en) * 2011-12-20 2013-06-27 Lifecell Corporation Flowable tissue products
US9198769B2 (en) 2011-12-23 2015-12-01 Pioneer Surgical Technology, Inc. Bone anchor assembly, bone plate system, and method
EP2806907A1 (en) 2012-01-24 2014-12-03 Lifecell Corporation Elongated tissue matrices
US9155578B2 (en) 2012-02-28 2015-10-13 DePuy Synthes Products, Inc. Expandable fastener
US9737294B2 (en) 2013-01-28 2017-08-22 Cartiva, Inc. Method and system for orthopedic repair
US9492288B2 (en) 2013-02-20 2016-11-15 Flexuspine, Inc. Expandable fusion device for positioning between adjacent vertebral bodies
EP2907481A1 (en) 2014-02-12 2015-08-19 HO-MED Handelsgesellschaft m.b.H. Implant for insertion between vertebrae of the spine and construction kit for making such an implant
US9517144B2 (en) 2014-04-24 2016-12-13 Exactech, Inc. Limited profile intervertebral implant with incorporated fastening mechanism
US9867718B2 (en) 2014-10-22 2018-01-16 DePuy Synthes Products, Inc. Intervertebral implants, systems, and methods of use

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551560A (en) * 1967-10-02 1970-12-29 Heinrich F Thiele Process of reconstructing tendons,cartilage,nerve sheaths,and products
CA962806A (en) * 1970-06-04 1975-02-18 Ontario Research Foundation Surgical prosthetic device
CA992255A (en) * 1971-01-25 1976-07-06 Cutter Laboratories Prosthesis for spinal repair
US3875595A (en) * 1974-04-15 1975-04-08 Edward C Froning Intervertebral disc prosthesis and instruments for locating same
US4085466A (en) * 1974-11-18 1978-04-25 National Research Development Corporation Prosthetic joint device
US4060081A (en) * 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
GB1515963A (en) * 1975-07-15 1978-06-28 Massachusetts Inst Technology Crosslinked collagen-mucopolysaccharide composite materials
US4280954A (en) * 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
CA1146301A (en) * 1980-06-13 1983-05-17 J. David Kuntz Intervertebral disc prosthesis
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US4344193A (en) * 1980-11-28 1982-08-17 Kenny Charles H Meniscus prosthesis
US4400833A (en) * 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4350629A (en) * 1981-07-29 1982-09-21 Massachusetts Institute Of Technology Procedures for preparing composite materials from collagen and glycosaminoglycan
US4458678A (en) * 1981-10-26 1984-07-10 Massachusetts Institute Of Technology Cell-seeding procedures involving fibrous lattices
US4505266A (en) * 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
US4544516A (en) * 1982-07-28 1985-10-01 Battelle Development Corporation Collagen orientation
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4448718A (en) * 1983-09-13 1984-05-15 Massachusetts Institute Of Technology Method for the preparation of collagen-glycosaminoglycan composite materials
GB8326542D0 (en) * 1983-10-04 1983-11-02 Johnson & Johnson Protein/polysaccharide complexes
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4627853A (en) * 1985-05-29 1986-12-09 American Hospital Supply Corporation Method of producing prostheses for replacement of articular cartilage and prostheses so produced
NL8700113A (en) * 1987-01-19 1988-08-16 Groningen Science Park A graft suitable for the treatment by reconstructive surgery, tissue-specific porosity, as well as method for the production of the graft.
US4880429A (en) * 1987-07-20 1989-11-14 Stone Kevin R Prosthetic meniscus
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US4911718A (en) * 1988-06-10 1990-03-27 University Of Medicine & Dentistry Of N.J. Functional and biocompatible intervertebral disc spacer

Also Published As

Publication number Publication date Type
JPH05508333A (en) 1993-11-25 application
DE69126971D1 (en) 1997-09-04 grant
EP0527936A1 (en) 1993-02-24 application
EP0527936B1 (en) 1997-07-23 grant
EP0527936A4 (en) 1993-07-28 application
CA2082427A1 (en) 1991-11-08 application
US5108438A (en) 1992-04-28 grant
DE69126971T2 (en) 1998-02-12 grant
WO1991016867A1 (en) 1991-11-14 application
JP3162375B2 (en) 2001-04-25 grant

Similar Documents

Publication Publication Date Title
Maas et al. Comparison of biomaterials for facial bone augmentation
Guarino et al. Bioactive scaffolds for bone and ligament tissue
US6730124B2 (en) Bone-tendon-bone assembly with cancellous allograft bone block
US5981825A (en) Device and methods for in vivo culturing of diverse tissue cells
US7169183B2 (en) Vertebral implant for promoting arthrodesis of the spine
US6852125B2 (en) Cartilage repair plug
US7217294B2 (en) Acellular matrix implants for treatment of articular cartilage, bone or osteochondral defects and injuries and method for use thereof
US6632246B1 (en) Cartilage repair plug
US5041138A (en) Neomorphogenesis of cartilage in vivo from cell culture
US5855619A (en) Biomatrix for soft tissue regeneration
US7368124B2 (en) Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US5759205A (en) Negatively charged polymeric electret implant
US7572291B2 (en) Osteochondral repair assembly including retracting spacer, kit and method
Moutos et al. Composite scaffolds for cartilage tissue engineering
US6283980B1 (en) Method, instruments, and kit for autologous transplantation
US20040138758A1 (en) Devices and methods for treating defects in the tissue of a living being
Yoshikawa et al. Bone tissue engineering with porous hydroxyapatite ceramics
US20060293760A1 (en) Soft tissue implants with improved interfaces
US5716404A (en) Breast tissue engineering
US6629997B2 (en) Meniscus-type implant with hydrogel surface reinforced by three-dimensional mesh
US5922027A (en) Articular cartilage heterografts
US6174333B1 (en) Biomatrix for soft tissue regeneration using mesenchymal stem cells
EP1493404A1 (en) Scaffold for connective tissue repair
US20070185585A1 (en) Implant Scaffold Combined With Autologous Tissue, Allogenic Tissue, Cultured Tissue, or combinations Thereof
US5522895A (en) Biodegradable bone templates

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry